News

Relay Therapeutics to Join Notable Investor Conferences in September

Relay Therapeutics to Join Notable Investor Conferences in September

Relay Therapeutics Announces Participation in Upcoming Investor Conferences

Relay Therapeutics, Inc. (Nasdaq: RLAY), based in Cambridge, Massachusetts, is making significant strides in the development of cutting-edge therapies aimed at transforming the lives of individuals battling cancer and genetic diseases. The company recently shared that its management team will engage in two prominent fireside chats scheduled for September.

Details on Conferences

The first event is the 2025 Wells Fargo Healthcare Conference, set for September 4, 2025, at 2:15 PM ET. Following shortly after, Relay Therapeutics will also be part of the Morgan Stanley 23rd Annual Global Conference, occurring on September 10, 2025, at 11:30 AM ET. These fireside chats are poised to be informative moments where management will discuss the company’s intricate initiatives and breakthroughs in precision medicine.

Accessing the Webcasts

Both discussions will be available for live streaming on Relay Therapeutics’ official website, particularly in the News & Events section. For those unable to attend the live sessions, archived replays will be accessible for up to 30 days post-event, ensuring that interested parties remain informed about the latest developments.

About Relay Therapeutics

Relay Therapeutics is recognized for its pioneering work in small molecule precision medicine. The firm is committed to advancing potentially transformative therapies for patients grappling with cancer and genetic disorders. Central to Relay's research is the innovative Dynamo platform, which combines state-of-the-art computational and experimental methodologies to target previously unapproachable protein targets. This platform positions Relay strongly at the forefront of medical innovation.

Clinical Advancement of RLY-2608

Relay's flagship clinical asset, RLY-2608, stands out as the first pan-mutant selective PI3K? inhibitor currently in clinical development. This innovative treatment is presently undergoing a Phase 3 trial, known as ReDiscover-2, focusing on HR+/HER2- metastatic breast cancer. In addition to this, RLY-2608 is also being evaluated for a set of genetic disease conditions characterized by PI3K?-driven vascular malformations.

Research Pipeline and Future Prospects

Looking ahead, Relay Therapeutics is nurturing a robust pipeline that includes several late-stage research initiatives targeting NRAS-driven solid tumors and the rare Fabry disease. The company remains committed to pushing the boundaries of what's possible in precision medicine, making significant impacts on patient care and treatment outcomes.

Stay Updated with Relay Therapeutics

More detailed information about Relay Therapeutics and its innovative approaches to therapy can be found on the company’s official website. They also invite individuals to connect and follow their latest updates on LinkedIn, ensuring that community members stay informed about their ongoing research and developments.

Contact Information

For inquiries regarding corporate affairs or media relations, interested parties can reach out to Pete Rahmer at prahmer@relaytx.com, or for media-related concerns, connect with Dan Budwick at 1AB by calling 973-271-6085 or emailing dan@1abmedia.com.

Frequently Asked Questions

What is Relay Therapeutics known for?

Relay Therapeutics is known for its work in developing precision medicines, specifically targeting cancer and genetic diseases through innovative therapies.

When are the upcoming investor conferences?

The conferences are the Wells Fargo Healthcare Conference on September 4, 2025, and the Morgan Stanley Global Conference on September 10, 2025.

How can I access the conference webcasts?

The live webcasts can be accessed through Relay Therapeutics’ website, specifically in the News & Events section.

What is RLY-2608?

RLY-2608 is Relay's lead clinical asset, a selective PI3K? inhibitor currently being tested in trials for metastatic breast cancer.

How can I stay updated with Relay Therapeutics?

You can visit Relay’s official website and follow their LinkedIn page for the latest updates on their research and developments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 11

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 5

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading
Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 4

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 6

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading

Top 5 Most Recently Viewed Articles

NXP Semiconductors Declares Significant Dividend for Shareholders

Updated Category News Views 97

NXP Semiconductors Grants Interim Dividend to Shareholders NXP Semiconductors N.V. has recently made headlines with the announcement of its latest interim dividend. This decision comes as part of the company’s ongoing commitment to return capital to shareholders while showcasing the strength of its financial health. The board's confidence truly emanates from NXP's solid...

Continue Reading
WEEX Expands Realm of Cryptocurrency with Innovative Dubai Studio

Updated Category News Views 152

WEEX Takes Center Stage at TOKEN2049 On May 1, 2025, WEEX, a premier cryptocurrency trading platform, made headlines at TOKEN2049 in Dubai, marking an exciting chapter in its global expansion. As a platinum sponsor at the event, WEEX showcased its innovative product offerings and strategic vision. The event attracted significant attention, with over 3,000 registrations...

Continue Reading
Talkspace and Wisdo Health Join Forces to Fight Loneliness

Updated Category News Views 184

Talkspace Teams Up with Wisdo Health to Combat Loneliness In a significant move for mental health advocacy, Talkspace, a prominent online behavioral healthcare provider, has announced a strategic partnership with Wisdo Health, an innovative platform dedicated to reducing loneliness among seniors. This collaboration marks a pivotal step towards enhancing mental health...

Continue Reading
Amanda Turcotte Joins Amalgamated Life as Chief Actuary

Updated Category News Views 569

Amalgamated Life Insurance Company Welcomes New Chief Actuary Amalgamated Life Insurance Company is thrilled to announce the appointment of Amanda Turcotte as their new Senior Vice President and Chief Actuary. In this pivotal role, Amanda will manage all actuarial functions, contributing to the company's mission of innovation in risk management and insurance solutions...

Continue Reading
Zoom's Innovative AI Companion Enhances Business Productivity

Updated Category News Views 283

Transforming Productivity with Zoom's AI Companion Zoom Communications, Inc. (NASDAQ: ZM) is revolutionizing how businesses operate through its groundbreaking AI Companion technology. Designed to save time and enhance collaboration, this AI-driven solution seamlessly connects with various third-party applications, facilitating an efficient workflow right from the Zoom...

Continue Reading